Dietary intake of cod and scallop reduces atherosclerotic burden in female apolipoprotein E-deficient mice fed a Western-type high fat diet for 13 weeks by Jensen, Ida-Johanne et al.
RESEARCH Open Access
Dietary intake of cod and scallop reduces
atherosclerotic burden in female
apolipoprotein E-deficient mice fed a
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Abstract
Background: It is now increasingly recognized that the beneficial effects of seafood consumption is not limited to
lipids and fatty acid, but that the protein part, i.e., peptides and amino acids, together with vitamins and even
unknown bioactive constituents also are important for disease prevention. This study was designed to evaluate the
putative anti-atherogenic effects of different protein sources (a lean seafood and a nonseafood) in apolipoprotein
E-deficient (apoE−/−) mice.
Methods: Twenty-four 5-week-old female apoE−/− mice were fed Western type diets containing chicken or a
combination of cod and scallops as dietary protein sources for 13 weeks. Atherosclerotic plaque burden, weight,
serum levels of leptin, glucose and LDL cholesterol as well as gene expressions from liver and heart were evaluated.
Statistical analyses were performed using SPSS. Differences between the variables were evaluated using independent
t-test or Mann–Whitney U test for normally and non-normally distributed variables, respectively. Normality was defined
by the Shapiro-Wilk test.
Results: The mice fed cod-scallop had a 24 % (p < 0.05) reduced total aorta atherosclerotic plaque burden compared
to the chicken fed group, whereas the reduction in plaque in the less lesion prone thoracic and abdominal parts of the
descending aorta were 46 % (p < 0.05) and 56 % (p < 0.05), respectively. In addition, mice fed cod-scallop gained less
weight, and had lower serum levels of leptin, glucose and LDL cholesterol, compared to those fed chicken. Analysis
of expression of the genes from liver and heart showed that hepatic endogenous antioxidant paraoxonase 2
(Pon2 gene) and the vascular cell adhesion molecule VCAM-1 (Vcam1 gene) were down regulated in mice fed
cod-scallop compared to mice fed chicken.
Conclusion: The present study revealed a metabolic beneficial effect of lean seafood compared to chicken, as
atherosclerotic plaque burden, serum glucose, leptin and LDL cholesterol levels were reduced in mice fed
cod-scallop.
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Background
In spite of tremendous developments in preventive and
acute treatment of cardiovascular diseases (CVD), CVD
is still the largest cause of morbidity and pre-mature
mortality worldwide [1]. Important factors that contrib-
ute to this is the increased consumption of energy dense
and processed foods together with a decline in physical
activity [2]. Atherosclerosis is a multifactorial inflamma-
tory condition affecting the arteries by plaque formation
and subsequent narrowing of the lumen. Diet has a
major impact on the atherosclerotic disease initiation
and progression and nutritional intervention is consid-
ered an effective and safe approach to health mainten-
ance and CVD prevention [3]. Indeed, a change in
nutritional pattern has been estimated to reduce CVD-
related deaths by up to 60 % [4].
A diet high in fish and seafood has long been acknowl-
edged to reduce risk of CVD [5–7], mainly due to the ef-
fects of the omega-3 fatty acids EPA (eicosapentaenoic
acid, 20:5n3) and DHA (docosahexaenoic acid, 22:6n3).
It has, however, become increasingly evident that the
beneficial effects of seafood consumption are not limited
to lipids and fatty acids. Proteins, peptides and amino
acids together with vitamins and even unknown bio-
active constituents may also be important for disease
prevention by controlling circulating levels of choles-
terol, lipoproteins and triglycerides, increasing endogen-
ous antioxidants and lowering blood pressure [8–13].
The exact mechanisms behind these effects, however, re-
main unknown.
Seafood is generally recognized as a rich source of tau-
rine [14] which might have a positive impact on CVD
[15, 16]. Recently, it was shown that male C57BL/6J
mice fed a high-fat, high-sugar diet containing scallop,
endogenously high in taurine and glycine, as protein
source, had improved plasma lipid profile, as compared
to mice fed high fat, high sugar diets with chicken fillet
or cod as the protein sources [17]. Thus, the present
study was undertaken to elucidate whether intake of a
Western-type diet with a mixture of cod and scallop
protein, as compared to chicken fillet, would prevent de-
velopment of CVD in the atherosclerosis-prone model
Apolipoprotein E-deficient (apoE−/−) mice.
A substantial metabolic beneficial effect of the marine
protein sources was documented, as atherosclerotic
plaque burden, serum glucose, leptin and LDL choles-
terol levels were reduced in mice fed cod-scallop.
Methods
Diets
The mice were fed a Western type diet (Research diet
D12079B, 17 energy percent protein, 43 energy percent
carbohydrates and 40 energy percent fat, Table 1) in
which the standard protein source casein was fully
exchanged with either chicken fillet or a mixture of cod
fillet and scallop muscle (1:1 on nitrogen basis). The
amino acid methionine was added to ensure adequate
metabolic balance. The lipid, protein and energy con-
tents were 20–21g/100g, 15.9–16.9g/100g and 20.2–
21.0kJ/g, respectively, and the cholesterol contents were
2.0 and 1.9g/kg for the chicken and cod-scallop diet
(Table 2). The amino acid compositions were similar
between the two diets (Table 3) with a few exceptions.
Histidine was more abundant in chicken than in the
cod-scallop diet, while the cod-scallop diet had almost
twice the amount of glycine compared to chicken diet
(10.1 and 5.7mg/g, respectively). Further, the cod-
scallop diet had a taurine content 5.3mg/g, whereas
chicken diet was almost devoid of taurine. The percent-
age distribution of fatty acids (Table 4) where similar
between the diets with the exceptions of EPA and DHA
which were higher in cod-scallop diet compared to
chicken diet and arachidonic acid which was higher in
the chicken diet compared to the cod-scallop diet.
Table 1 Composition of experimental diets (g/kg)
Dietary treatments
Chicken Cod-scallop
Chicken fillet 189.8 0
Cod fillet 0 92.9
Scallop 0 102.9
L-methionine 3 3




Milk fat (anhydrous) 200 200
Corn oil 10 10
Mineral mix S1001 35 35
Calcium carbonate 4 4
Vitamin mix V1001 10 10
Choline bitartrate 2 2
Cholesterol 1.1 1.1
Ethoxyquin 0.04 0.04
Table 2 Analyzed composition of the experimental diets (g/kg)
Dietary treatments
Chicken Cod-scallop
Crude protein (N*6.25) 169 159
Fat 210 200
Cholesterol 2.0 1.9
Gross energy (kJ/g) 21 20.2
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Protein, lipid and energy content of feed
The feed was analyzed for crude protein, total fat and
gross energy content. Nitrogen content was determined
after combustion using the Dumas method (Leco FP-
528, ISO 34/SC 5, ON, Canada) and crude protein con-
tent was calculated as nitrogen content multiplied by
6.25. Gross energy was determined using an automatic
adiabatic calorimeter (Model 1241; Parr Instruments,
Moline, IL, USA). Total fat was determined gravimetri-
cally by extraction with organic solvents before and after
acidic hydrolysis, as described previously [17]. The
amino acid composition was determined after acidic hy-
drolysis by the Acquity UPLC system (Waters, USA), the
tryptophan content was determined after basic hydroly-
sis on a HPLC system (Shimadzu, USA) as described
previously in details [17]. Total cysteine in the samples
was determined after oxidation of cysteine/cystine with
9:1 performic acid (88 %): H2O2 (30 %) (v/v) to yield
cysteic acid. Total cysteine analysis was performed by
the Norwegian Institute of Food, Fishery and
Aquaculture (Bergen, Norway). Total cholesterol was de-
termined on a Thermo Trace 2000 GC equipped with a
flame ionization detector (FID) operated under condi-
tions described elsewhere [18]. Prior to injection on the
GLC, the samples had been added internal standard α-5
cholestan, saponified in 0.5M NaOH/MeOH at 80 °C for
15 min, hexan-extracted, dried under N2 at 60 °C, and
resuspended in hexan.
Animals and housing
Apolipoprotein E-deficient mice fed a Western type,
high fat diet, were used as model system. Such apoE−/−
mice develop atherosclerosis spontaneously with similar
characteristics as those seen in humans [19, 20] and are
extensively used to study dietary effects on atheroscler-
osis. Twenty-four female apoE−/− mice (B6.129P2-
Apoetm1UncN11), 5-weeks-old, were obtained from
Taconic, Denmark. After one week of acclimation, the
mice were ear marked and randomly assigned to the
experimental groups (n = 12/group) with equal number
of cages per treatment (n = 4 cages/diet). All mice were
housed in individually ventilated cages in the same
room at 21 °C and 55 % relative humidity, on a 12 h
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SAA sum amino acids; 1Sum of essential amino acids (histidine, isoleucine,
leucine, methionine, lysine, valine, tryptophane, threonine, phenylalanine).
2Sum of branched-chain amino acids (isoleucine, leucine and valine)
Table 4 Fatty acid (FA) composition as percentage of total FA
and mg/g of the experimental diets
Dietary treatments
Chicken Cod-scallop
FA % mg/g % mg/g
<14:00 8.4 15.7 8.2 14.3
14:00 10.3 19.1 10.6 18.4
16:00 28 52.0 28.2 48.8
16:1n7 1.5 2.83 1.5 2.56
18:00 10.7 20.0 10.6 18.4
18:1n9 23.6 43.9 22.6 39.1
18:1n7 1.0 1.8 1 1.7
18:2n6 5.4 10.0 4.2 7.27
18:3n3 0.7 1.2 0.6 0.97
20:1n9 0.1 0.2 0.1 0.17
20:4n6 0.2 0.4 0.1 0.24
20:5n3 0.1 0.1 0.5 0.79
22:5n3 0.1 0.23 0.1 0.21
22:6n3 0.1 0.17 0.7 1.25
SFA 59.2 110 59.6 103
MUFA 29.7 55.2 28.8 49.9
n-3 1.0 1.76 1.9 3.22
n-6 5.6 10.4 4.3 7.51
n6/n3 5.6 5.9 2.3 2.3
Sum identified 96.1 179 95.3 165
Sum nonidentified 3.9 7.29 4.7 8.08
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day/night cycle (light: 0600 to 1800 h) in a conventional
laboratory animal unit. The mice had unrestricted ac-
cess to feed that was distributed in wire bar lids with
food hoppers for 13 weeks. Cages and bedding were
changed once per week. After 13 weeks of feeding, the
mice were feed-deprived for 3 h before they were eu-
thanized by carbon dioxide inhalation. Blood was
drawn by cardiac puncture and serum separated and
frozen at −80 °C. Tissues were dissected out, weighted,
snap frozen and kept at −80 °C. The study was ap-
proved by the Norwegian Animal Research Authority
(Approval number 3277) and performed following
Federation of European Laboratory Animal Science
Associations recommendations and according to the
Norwegian legislation on the care and use of experi-
mental animals. The mice were pathogen free, stated by
a health certificate. Adverse events were not observed.
Analysis of atherosclerosis
After blood removal by cardiac puncture, the mouse was
immediately perfused through the left ventricle with
sterile saline (0.9 %) for approximately 5 min until no re-
sidual blood was apparent in the circulation. The entire
aorta from the proximal ascending aorta to the bifur-
cation of the iliac arteries was dissected and cleaned in
situ from periadventitial fat. The aorta was opened
longitudinally, fixed and prepared by lipid Oil Red O-
staining and subjected to whole mount en face evalu-
ation as previously described [21]. Aorta images were
made by scanning the objective on a high resolution
scanner and lesion areas were evaluated using ImageJ
software [22]. The extent of atherosclerotic burden was
reported as percentage of the total area of an artery, or
artery region, i.e., the aortic arch, the thoracoabdominal
part of the descending aorta (thoracic area), and the in-
frarenal part down to the iliac bifurcation (abdominal
area), occupied by atherosclerotic lesions.
RNA-isolation
Total RNA was isolated from liver and heart tissue. Im-
mediately after perfusion, tissue was dried, weighted and
frozen in liquid nitrogen and kept at −80 °C until ana-
lysis. Tissue (30mg to 90mg) was cut in liquid nitrogen
and homogenized in 1 ml Trizol (Invitrogen) using a
bead miller (Precellys 24, Bertin Technologies). After
centrifuging the homogenate for 10 min at 12000g and
4 °C, the supernatant was mixed generously with 0.2
volumes chloroform, incubated 30 min on ice and cen-
trifuged for 20 min at 12000g and 4 °C. The aqueous
phase was mixed with 0.5 volumes fresh isopropanol
and incubated on ice for a minimum of 2 h before 30
min centrifugation at full speed (21000g) and 4 °C. The
remaining pellet was washed with ice-cold 80 % etha-
nol, centrifuged 5 min at 21000g and 4 °C, dried and
dissolved in RNA storage solution (Ambion) and stored
at −80 °C. RNA concentration was determined using a
Qubit 1.0 fluorometer (Life technologies) and the RNA
integrity was evaluated using a 2100 Bioanalyzer Instru-
ment (Agilent Technologies). The relative integrity
numbers of the isolates were between 8.1 and 9.4.
Reverse transcription and quantitative real-time PCR
Reverse transcription was performed in triplicate using
the high capacity cDNA RT kit (Applied Biosystems)
with 50ng RNA in 20μl reactions. Four μl cDNA (12.5ng
of reverse transcribed RNA) per 20μl reaction was ana-
lyzed by quantitative RT-PCR using predesigned TaqMan®
Gene Expression assays (Additional file 1: Table S1) and
TaqMan Fast Universal PCR Master Mix (Applied Biosys-
tems) in 96-well plates with an ABI Prism 7500 Fast
Cycler (Applied Biosystems). The amplification profile
was 95 °C for 20s followed by 40 cycles of 95 °C for
3s and 60 °C for 30s. Endogenous reference genes
were selected using the TaqMan Array Mouse Endogen-
ous Control assays. From this panel of 32 housekeeping
genes, the two most stably expressed control genes (Hprt
and Tbp) were selected, and the geometric mean of the
two was used to normalize gene expressions. The calcula-
tions were made using the relative expression software
tool [23]. All assays included no-template-controls and an
inter plate calibrator.
Serum cholesterol, triglyceride, glucose and total protein
concentrations
The serum cholesterol, LDL cholesterol, triglyceride,
glucose and total protein concentrations were deter-
mined by conventional enzymatic kits using a MaxMat
bioanalyzer (MaxMat PL II, Montpellier, France).
Hepatic fat and fatty acid analysis
Total hepatic fat was extracted using dichloromethane
and methanol, and determined gravimetrically [24]. The
fatty acid composition of the liver samples was deter-
mined as previously described [25].
Serum cytokines, chemokines and hormones
Serum samples were analyzed in duplicates according to
the manufacturers’ instructions using a MSD Mouse
Proinflammatory panel 1 V-Plex kit (MULTI-ARRAY®,
Meso Scale Discovery, Gaithersburg, MD) and a Bio-
Plex Pro Mouse Diabetic Assay (MAGPIX, Bio-Rad,
Copenhagen, Denmark). Serum cytokines, chemokines
and hormones analyzed were IFN-γ, IL-1β, IL-2, IL-4,
IL-5, IL-6, IL-10, IL-12p70, KC/GRO, and TNF-α using
MSD and glucagon, insulin, leptin, monocyte chemotac-
tic protein-1 (MCP-1), and regulated upon activation,
normal T cell expressed and secreted (RANTES) using
Bio-Plex (Bio-Rad).
Jensen et al. Nutrition & Metabolism  (2016) 13:8 Page 4 of 11
Statistical analysis
The results are presented as mean ± standard error of
the mean. SPSS 19.0 (SPSS Inc., Chicago, IL) was used
to perform statistical analysis of the data. The Shapiro-
Wilk test was performed to determine the distribution
of the variables and non-normal distributions were log-
transformed before statistical analysis with an independent
t-Test. Variables that were non-normally distributed after
log-transformation were analyzed with Mann–Whitney U
test. Bivariate analyses of correlation between parameters
were assessed by Pearson’s correlation coefficient. Differ-
ences were considered significant when p < 0.05.
Results
General outcomes and mice growth
The mice appeared in good physical shape and gained
weight throughout the experimental period. The excep-
tions were two mice in the cod-scallop group that were
euthanized due to weight loss during the first weeks of
the study. These two mice were small at arrival and
should probably have been removed prior to the start of
the study. Although the average daily energy intake was
similar in both groups (p = 0.88), the mice fed chicken
protein had gained significantly more weight than mice
fed cod-scallop protein (21.4g vs 16.6g, p < 0.05) at the
end of the experiment (Fig. 1). The visceral adipose tis-
sue, represented by the epididymal and the perirenal fat,
weight was higher (3.15g vs 2.45g, p < 0.05) in the
chicken fed group compared to the cod-scallop fed
group (Fig. 2a), but when calculated as relative to body
weight, no significant difference was observed (Fig. 2b).
Heart weight was not different between cod-scallop and
chicken fed mice.
Atherosclerotic lesions
The atherosclerotic lesions were predominantly distrib-
uted in the aortic arch and in the areas surrounding the
branching points of the major arteries (Fig. 3). The
plaque burdens in the aorta thoracic, abdominal as well
as total area were reduced by 46 %, 56 % and 24 % (p =
0.004, 0.003 and 0.044), respectively in mice fed cod-
scallop compared to mice fed chicken. Also in the most
plaque prone area, the aortic arch, the cod-scallop fed
mice had lower plaque burden, however, the difference
did not reach statistical significance (p = 0.09).
Hepatic fat content and fatty acid composition
The hepatic fat content extracted with dichloromethane/
methanol was higher in chicken fed mice compared to
cod-scallop fed mice (430mg/g and 330mg/g, respect-
ively, p < 0.05) (Table 5). The concentration of hepatic
fatty acids was borderline (p = 0.054) higher in chicken
fed mice compared to cod-scallop fed mice, 194 versus









































































Fig. 1 Feed intake and weight. (a) average daily feed intake (kJ/
mice); (b) final body weight; (c) body weight gain (g) of female
apolipoprotein E-deficient mice fed diets containing different protein
sources for 13 weeks. Data are mean ± SEM. Average daily feed intake
was analyzed using the non-parametric Mann–Whitney U test, while
final body weight and body weight gain were analyzed using the
independent samples t-Test. * denotes significant difference between
mice fed chicken protein (n = 12) and mice fed cod-scallop
protein (n = 10)
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fatty acid amount (fatty acid concentration x liver mass),
the chicken fed mice had elevated amounts of total hep-
atic fatty acids (Table 5). The fatty acid compositions
evaluated in liver tissues (Table 6) showed that the group
receiving the cod-scallop diet had higher (p < 0.001) per-
centage of saturated fatty acids (SFA) compared to the
chicken group (30 % and 25 %, respectively). The percent-
age of linoleic acid was similar (approximately 5.0 %), EPA
was only detected in the cod-scallop group, and both DPA
and DHA were higher (p < 0.001) in the cod-scallop fed
group compared to the chicken fed group (0.7 and 0.5 %
DPA and 3.7, and 1.2 %DHA, respectively). However,
when presented as mg/g liver tissue, the group receiving
the cod-scallop diet had similar levels of SFA, lower levels
of MUFA, and higher levels of EPA, DPA and DHA. The
n6/n3 ratio was higher in the chicken fed group (4.3 vs
1.2) and the opposite was true for SFA/monounsaturated
fatty acids (MUFA) ratio (0.4 in the chicken fed group and
0.6 in the cod-scallop fed group). The 16:1n7/16:0 ratios
were 0.20 and 0.15 for chicken fed and cod-scallop fed
mice, respectively.
Serum cholesterol and lipid levels
Serum LDL-cholesterol was significantly lower in the
cod-scallop fed mice compared to the chicken fed mice,





















































Fig. 2 Tissue weights and relative tissue weights of female apolipoprotein E-deficient mice. The mice were fed diets containing different protein
sources for 13 weeks. Data are mean ± SEM. a Data from liver and visceral adipose tissue were analyzed using the independent samples t-Test.
Data from heart were analyzed using the non-parametric Mann–Whitney U test. * denotes significant difference in tissue weight between mice
fed chicken protein (n = 12) and mice fed cod-scallop protein (n = 10). b Data from liver were analyzed using the independent samples t-Test.
Data from adipose tissue were log transformed before analysis using the independent samples t-Test. Data from heart were analyzed using the
non-parametric Mann–Whitney U test. * denotes significant difference in relative tissue weight between mice fed chicken protein (n = 12) and
mice fed cod-scallop protein (n = 10)
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concentrations of total cholesterol nor triglyceride dif-
fered significantly between the chicken and cod-scallop
fed groups (Table 7).
Serum glucose, protein, cytokine, chemokine and
hormone concentrations
Serum glucose concentrations differed between mice fed
cod-scallop and chicken, being lower (p < 0.05) in the
cod-scallop fed group (16.7mmol/l) compared to the
chicken fed group (19.6mmol/l) (Table 7). Total protein
content in serum did not differ between cod-scallop and
chicken fed mice (95.4g/l and 86.8g/l, respectively)
(Table 7). Leptin was higher (p < 0.01) in the chicken fed
group (40.3pg/ml) compared to the cod-scallop fed
group (25.4pg/ml) (Table 8). Serum levels of the cyto-
kines and chemokines IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-
6, IL-10, IL-12p70, KC/GRO, TNF-α, MCP-1, and
RANTES did not differ between the groups (data now
shown). Three hours feed-deprived serum concentra-
tions of insulin and glucagon did not differ between the
two groups (Table 8). Insulin concentrations were 1.4ng/
ml in both groups and glucagon concentrations were
700pg/ml and 1000pg/ml for chicken and cod-scallop
fed mice, respectively.
Gene expression
The gene expression assays used for analysis of liver
were chosen to include genes involved in cholesterol,
lipoprotein and lipid metabolism, inflammatory response































Fig. 3 Atherosclerotic plaque burden. The plaque burden is expressed as area percentage covered by lipid Oil Red O staining, in female apolipoprotein
E-deficient mice fed diets containing different protein sources for 13 weeks. Data are mean ± SEM and were analyzed using the independent samples
t-test. * denotes significant difference in atherosclerotic lesion between mice fed chicken protein (n = 12) and mice fed cod-scallop protein (n = 10)
Table 5 Lipid content and total fatty acids (FA) (mg/g) of
hepatic tissue from apoE−/− mice
Dietary treatments
Chicken (n = 12) Cod-scallop (n = 10)
Lipid (mg/g liver) 430 ± 23 330 ± 35*
FA(mg/g fat) 194 ± 11 153 ± 16
FA (mg/g)*liver weight 423 ± 37 320 ± 28*
The mice were fed different protein sources for 13 weeks. Data are mean ±
SEM (n = 10–12). Data were analyzed using the independent samples t-Test.
*indicate significant difference (p < 0.05) between diet groups
Table 6 Fatty acid (FA) composition as percentage of total FA
and mg/g of hepatic tissue from apoE−/− mice
Dietary treatments
Chicken (n = 12) Cod-scallop (n = 10)
FA % mg/g % mg/g
14:00 0.98 ± 0.0 1.88 ± 0.1 0.87 ± 0.0 1.34 ± 0.2*
16:00 22.5 ± 0.3 43.6 ± 2.6 25.09 ± 0.6* 38.51 ± 4.0
16:1n7 4.61 ± 0.4 8.96 ± 0.9 3.74 ± 0.2 5.66 ± 0.5*
18:00 3.08 ± 0.1 5.91 ± 0.3 4.13 ± 0.2* 6.17 ± 0.5
18:1n9 45.03 ± 1.4 87.6 ± 6.0 41.95 ± 0.7* 64.44 ± 6.6*
18:1n7 5.12 ± 0.4 9.92 ± 0.9 3.55 ± 0.1* 5.38 ± 0.5*
18:2n6 4.93 ± 0.3 9.59 ± 0.8 4.96 ± 0.1 7.55 ± 0.7
20:1n9 0.63 ± 0.0 1.24 ± 0.1 0.42 ± 0.0* 0.60 ± 0.1*
20:4n6 1.25 ± 0.1 2.42 ± 0.2 1.09 ± 0.1 1.57 ± 0.1*
20:5n3 Bdl 0.95 ± 0.1 1.40 ± 0.1
22:5n3 0.52 ± 0.1 0.98 ± 0.1 0.71 ± 0.1* 1.04 ± 0.1*
22:6n3 1.18 ± 0.1 2.28 ± 0.2 3.66 ± 0.2* 5.38 ± 0.3*
SFA 24.63 ± 2.0 47.58 ± 4.7 30.09 ± 0.6* 46.02 ± 4.6
MUFA 55.40 ± 2.1 107.68 ± 7.7 49.54 ± 0.8* 75.92 ± 7.6*
n-3 1.70 ± 0.1 2.97 ± 0.3 5.31 ± 0.3* 7.82 ± 0.5*
n-6 6.18 ± 0.4 12.01 ± 1.0 6.05 ± 0.2 9.12 ± 0.8*
n6/n3 4.27 ± 0.3 1.2 ± 0.0*
16:1n7/16:0 0.20 0.15
Sum identified 87.78 ± 0.7 170.30 ± 10.3 91.04 ± 0.7 138.93 ± 4.7
Sum unidentified 12.22 ± 0.7 23.35 ± 1.4 8.97 ± 0.7 13.52 ± 2.1
The mice were fed diets containing different protein sources for 13 weeks.
Data are mean ± SEM (n = 10–12). Data were analyzed using the non-
parametric Mann–Whitney U test. *indicate significant difference (p < 0.05). Bdl,
below detection limit of 0.5 area %
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in several phases of the atherosclerotic process (Table 9).
Hepatic expression of the genes encoding the antioxida-
tive protein paraoxonase 2 (Pon2) and vascular cell ad-
hesion protein 1 (Vcam1) were down regulated in mice
fed cod-scallop compared to mice fed chicken. Hepatic
expression of all the other investigated genes were un-
affected by the dietary intervention. The effects of the
two diets on the cardiac function and homeostasis were
also investigated by means of gene expression analysis of
a battery of genes related to heart function, fibrosis and
apoptosis. There were, however, no significant differ-
ences between cardiac gene expression of mice fed
chicken or cod-scallop (Table 9).
Discussion
The main purpose of this study was to evaluate the ef-
fect of different protein sources on atherosclerotic devel-
opment using female apoE−/− mice fed a Western-type
diet. The protein sources were chicken or cod and scal-
lop (1:1 on nitrogen basis). The reason for combining
cod and scallop was to create a lean marine protein
source high in taurine and glycine. Chicken was chosen
because it is considered a healthy and lean protein
source of terrestrial origin [26]. Mice fed the cod-scallop
diet for 13 weeks had significantly reduced aorta athero-
sclerotic plaque burden compared to chicken fed mice.
Diets rich in seafood are generally recommended to
humans due to the triglyceride lowering and anti-
inflammatory effects of EPA and DHA [27]. However, in
the present study, the serum concentration of triglycer-
ides did not differ significantly between the two groups.
A triglyceride lowering effect of EPA and DHA has
mainly been shown at pharmaceutical doses and is not
commonly evident at nutritional levels [28] as given in
the present study. When the cholesterol content in the
Table 7 Serum lipids, glucose and total protein concentrations
in apoE−/− mice
Dietary treatments
Chicken (n = 12) Cod-scallop (n = 10)
Cholesterol (mmol/l) 24.20 ± 0.9 21.84 ± 0.7
LDL-Cholesterol (mmol/l) 13.97 ± 0.57 12.49 ± 0.37*
Triglycerides (mmol/l) 1.90 ± 0.2 2.16 ± 0.2
Glucose (mmol/l) 19.60 ± 1.0 16.68 ± 0.6*
Total protein (g/l) 95.40 ± 3.7 86.76 ± 4.5
The mice were fed diets containing different protein sources for 13 weeks.
Data are mean ± SEM (n = 10–12). Data were analyzed with the independent
samples t-Test. Data for triglycerides were analyzed using the non-parametric
Mann–Whitney U test. *indicate significant difference (p < 0.05) between
dietary treatments
Table 8 Serum concentrations of glucagon, insulin and leptin
in apoE−/− mice
Dietary treatments
Chicken (n = 12) Cod-scallop (n = 10)
Glucagon (pg/ml) 698 ± 202 1054 ± 333
Insulin (ng/ml) 1.4 ± 0.4 1.4 ± 0.5
Leptin (pg/ml) 40.3 ± 11.6 25.4 ± 8.0*
The mice were fed diets containing different protein sources for 13 weeks.
Data are mean ± SEM (n = 10–12). Data for leptin were analyzed using the
independent samples t-Test. Data for insulin were log transformed before
analysis using the independent samples t-Test. Data for glucagon were
analyzed using the non-parametric Mann–Whitney U test. * indicate significant
difference (p < 0.05) between dietary treatments
Table 9 Relative gene expressions in liver and heart of apoE−/−
mice
Gene Chicken Cod-scallop Gene Chicken Cod-scallop
Liver Heart
Cytokines and chemokines Cytokines and chemokines
Ccl2 1.0 ± 0.11 0.85 ± 0.05 Ccl2 1.0 ± 0.12 0.80 ± 0.10
Il1b 1.0 ± 0.13 0.86 ± 0.05 Ilb1 1.0 ± 0.16 1.20 ± 0.38
Icam1 1.0 ± 0.13 0.97 ± 0.05 Icam1 1.0 ± 0.06 1.03 ± 0.11
Vcam1 1.0 ± 0.06 0.81 ± 0.06* Cardiac function and homeostasis
Endogenous antioxidant system Agtr1 1.0 ± 0.08 1.09 ± 0.13
Pon2 1.0 ± 0.04 0.84 ± 0.04* Ankrd1 1.0 ± 0.13 1.03 ± 0.24
Nfe212 1.0 ± 0.05 0.94 ± 0.04 Nppa 1.0 ± 0.31 1.17 ± 0.43
Sod1 1.0 ± 0.05 1.04 ± 0.07 Nppb 1.0 ± 0.21 1.07 ± 0.34
Sod2 1.0 ± 0.03 1.05 ± 0.03 Myh6 1.0 ± 0.04 1.10 ± 0.08
Gpx1 1.0 ± 0.05 1.01 ± 0.04 Myh7 1.0 ± 0.15 0.80 ± 0.12
Gpx4 1.0 ± 0.04 1.04 ± 0.04 Angiogenesis
Ucp2 1.0 ± 0.13 0.94 ± 0.08 Vegfb 1.0 ± 0.06 1.07 ± 0.15
Cholesterol and lipoprotein metabolism Apoptosis
Abcg5 1.0 ± 0.26 0.89 ± 0.09 Bcl2 1.0 ± 0.07 0.99 ± 0.07
Abcg8 1.0 ± 0.25 0.77 ± 0.07 Casp3 1.0 ± 0.08 1.14 ± 0.14
Acat2 1.0 ± 0.21 0.95 ± 0.05 Fibrosis
ApoB 1.0 ± 0.18 0.98 ± 0.05 Col1A1 1.0 ± 0.06 1.10 ± 0.12
Cyp7a1 1.0 ± 0.26 0.89 ± 0.06 Col3A1 1.0 ± 0.06 1.01 ± 0.09
Hmgcr 1.0 ± 0.08 1.05 ± 0.07 Fn1 1.0 ± 0.04 1.07 ± 0.14
Ldlr 1.0 ± 0.25 0.81 ± 0.05 Timp1 1.0 ± 0.24 0.89 ± 0.15
Srb1 1.0 ± 0.52 0.37 ± 0.02
Vldr1 1.0 ± 0.20 1.05 ± 0.09
Nitrogen and fatty acid metabolism
Cps1 1.0 ± 0.09 1.17 ± 0.08
Cpt1a 1.0 ± 0.06 0.98 ± 0.06
Acox1 1.0 ± 0.05 1.05 ± 0.02
Acaca 1.0 ± 0.17 1.01 ± 0.19
Scd1 1.0 ± 0.31 1.91 ± 0.30
Adipoq 1.0 ± 0.58 0.99 ± 0.07
Adipor 1.0 ± 0.05 0.93 ± 0.02
Ffar1 1.0 ± 0.11 1.11 ± 0.06
The mice were fed diets containing different protein sources for 13 weeks.
Data are mean ± SEM (n = 10–12)
*Indicate significant difference (p<0.05) between dietary treatments.
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two diets was analyzed, it was found that the chicken
diet contained 0.20 % cholesterol whereas the cod-
scallop diet contained 0.19 % cholesterol, but this small
difference is not sufficient to cause a reduction in aorta
atherosclerosis per ce. Taurine is known to reduce chol-
esterol levels in blood by increased cholesterol clearance
from blood circulation, bioconversion of cholesterol to
bile acid in liver and excretion of cholesterol and bile
acids from the intestine [29]. Hence, the higher dietary
level of taurine in the cod-scallop diet was expected to
contribute to a reduced level of circulating cholesterol.
Indeed, a reduced level of serum LDL cholesterol was
observed in the cod-scallop fed mice compared to the
chicken fed mice, whereas we did not find a significant
reduction of serum total cholesterol in the cod-scallop
fed mice compared to the chicken fed mice.
The mice fed chicken protein gained more weight than
mice fed cod-scallop protein and body weight, visceral
white adipose tissue weight and liver lipid content was
higher in chicken fed mice compared to cod-scallop fed
mice. A positive correlation between satiety and blood
taurine concentrations in humans has been reported
[30], and it has been demonstrated that taurine supple-
mentation of male mice affected energy intake and pre-
vented a high-fat diet induced obesity [31]. In this study,
however, the feed consumption was equal in the two
groups suggesting that metabolism was affected differ-
ently. In a recent study by Tastesen et al. [17], it was
shown that dietary taurine and glycine correlated in-
versely with body fat mass. The mechanisms, however,
remain unknown. Choice of dietary protein source has
been documented to affect energy metabolism and to be
associated with diet-induced obesity in rats [32, 33]. Rats
fed fish protein hydrolysates have been shown to have
elevated plasma bile acids and reduced visceral adipose
tissue relative to a casein fed control group [32, 33]. The
plasma concentrations of bile acids were not measured
in this study, hence the exact mechanisms behind the
weight gain difference, were not elucidated.
Furthermore, the cod-scallop fed mice had lower con-
centration of leptin compared to chicken fed mice. This
is most probably due to the lower content of adipose tis-
sue, which is the primary site of leptin production. Lep-
tin is a key hormone in regulation of food intake and
energy expenditure [34]. Lately it has also been demon-
strated to play a direct role in almost every step in the
development of atherosclerotic plaques [35]. It has pre-
viously been reported for both humans and rodents that
obesity is associated with leptin resistance and that
obese individuals have elevated leptin levels without any
down-regulation of food intake [36]. Leptin is also indi-
cated to function as a proinflammatory adipokine, and
to further investigate the effect on the inflammatory re-
sponse, we analyzed both circulating levels and hepatic
expression of several inflammatory markers. Expression
of the Vcam1 gene encoding the cellular adhesion mol-
ecule VCAM-1 was lower in the cod-scallop fed mice.
This protein mediates firm adhesion of leukocytes that
then migrate into the sub-endothelium. The Vcam1 gene
is normally up regulated by hyperlipidemia and by
inflammatory cytokines [37], proposing a potentially
higher inflammatory condition in the chicken fed mice.
However, hepatic expressions of inflammatory marker
genes such as Ccl2, Il1b, and Icam1 were not influenced
and serum levels of inflammatory proteins were un-
altered between the two groups. The level of atheroscler-
otic plaque formation observed in this study represents
levels found in asymptomatic, apparently healthy
humans [38] and not surprisingly the serum levels of cy-
tokines and chemokines are unaffected by the dietary
intervention in this model.
It is well accepted that oxidative stress may accelerate
the development of atherosclerosis [39] with subsequent
up-regulation of cellular antioxidants such as the protein
PON2 [40]. In the cod-scallop fed mice the expression
of the Pon2 gene was lower compared to chicken fed
mice, suggesting lower oxidative stress, which may be a
possible explanation for the reduced atherogenesis. Tau-
rine is known to possess antioxidative capacity [41] and
may have attributed to the lower oxidative stress in the
cod-scallop fed group.
In the present study, the dietary concentrations of n-3
PUFAs were higher, and of SFA and MUFA were lower
in the cod-scallop diet as compared to in the chicken
diet. Compared to the chicken fed mice, the mice fed
cod-scallop diet had similar liver levels of SFA, lower
levels of MUFA and higher levels of EPA, DPA and
DHA, and further a correspondingly lower n-6/n-3 ratio.
An antiatherosclerotic effect of marine n-3 PUFA have
previously been observed both in the apoE−/− mouse
model [21] and in the Ldlr−/− mouse model [42–45]. As
previously mentioned, the amounts of n-3 PUFA given
in the present study were lower compared to the previ-
ous studies. However, we cannot exclude the possibility
that the dietary fatty acid composition contributed to
the observed effects in the present study.
In a clinical human setting, atherosclerosis leads to
hemodynamic stress often followed by a compensatory
hypertrophic growth of the heart and ultimately plaque
rupture and ischemic heart disease. To search for detect-
able differences in cardiac gene expression of markers of
heart function and homeostasis, fibrosis, apoptosis and
angiogenesis, RNA was isolated from cardiac apices from
the mice. No differences were found between mice fed
chicken and mice fed cod-scallop in any of the tested
genes, indicating that the diets did not affect the heart.
This was supported by the lack of hypertrophic growth
of the cardiac muscle. There is however little evidence
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indicating that the heart would be affected considering
the low levels of dietary cholesterol given to the mice
and the low atherosclerotic burden observed in the mice,
and substantial effects on the heart was not expected.
Conclusions
This study has demonstrated a beneficial metabolic ef-
fect in the mice fed cod-scallop compared to the mice
fed chicken, as aorta atherosclerotic burden, body
weight, visceral adipose tissue, serum glucose and leptin
levels, all were reduced. The results warrant further in-
vestigations to elucidate in detail the molecular mecha-
nisms underlying the observed effects.
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